2024-11-14T15:40:04-06:00 2023-12-31 330310569 HASKELL & WHITE LLP 300 SPECTRUM CENTER DR STE 300 IRVINE CA 92618 990 2023-01-01 330632830 CALIFORNIA TRANSPLANT SERVICES INC CALI 7608046890 5845 OWENS AVENUE CARLSBAD CA 92008 DARYL LIRMAN CEO 7608046890 2024-11-14 1 0 RICK SMETANKA P01677376 9494506200 2023 2024-10-15 13:58:12Z DARYL LIRMAN 5845 OWENS AVENUE CARLSBAD CA 92008 2200834 0 X WWW.CATRANSPLANT.ORG X 1994 CA THE MISSION OF CTS IS TO PROVIDE PROGRAM SERVICES AS A NON-PROFIT EYE AND TISSUE BANK, TO PROVIDE EDUCATION AND IN-SERVICE TRAINING TO MEDICAL PROFESSIONALS, AND COMMUNITY EDUCATION REGARDING EYE AND TISSUE DONATION. TO PROVIDE TISSUE PRESERVATION & CRYOGENIC STORAGE OF AUTOLOGOUS TISSUE FOR LIVING PERSONS DUE TO TRAUMATIC HEAD INJURY OR OTHER ILLNESS INVOLVING SWELLING OF THE BRAIN REQUIRING REMOVAL AND STORAGE OF SKULL BONE, AND TO PROVIDE LONG-TERM STORAGE OF BANKED BONE. 4 2 3 3 0 0 23 20 1878957 1936771 243011 264043 0 0 2121991 2200834 0 0 0 0 864515 874766 0 0 0 626464 623859 1490979 1498625 631012 702209 10227193 11052767 612447 735812 9614746 10316955 X THE MISSION OF CALIFORNIA TRANSPLANT SERVICES, INC. IS TO ACT AS A RESPONSIBLE STEWARD ON BEHALF OF OUR COMMUNITY OF ANATOMICAL DONATIONS THAT ARE GIFTED FOR TRANSPLANT AND RESEARCH; GIFTS THAT ARE GIVEN SELFLESSLY BY VERY SPECIAL PEOPLE SO OTHERS MAY ENJOY A LONGER AND BETTER QUALITY OF LIFE. 0 0 1333030 1936771 100% OF PROGRAM SERVICE REVENUE FOR 2023 WAS RECEIVED FROM FEES FOR SERVICES RELATED TO EYE AND TISSUE BANKING ACTIVITIES. CTS DISTRIBUTES OCULAR TISSUE FOR SIGHT RESTORATIVE SURGERIES. OCULAR TISSUE CTS DISTRIBUTES IS RECOVERED AND PROCESSED BY EYE BANKS THAT ARE REGISTERED WITH THE FDA & MEMBERS OF THE EYE BANK ASSOCIATION OF AMERICA. CTS ALSO DISTRIBUTES ALLOGRAFT TISSUE FOR RECONSTRUCTIVE SURGERY. ALLOGRAFT TISSUE DISTRIBUTED BY CTS IS RECOVERED AND PROCESSED BY TISSUE BANKS THAT ARE ACCREDITED MEMBERS OF THE AMERICAN ASSOCIATION OF TISSUE BANKS, AND REGISTERED WITH THE FDA. CTS IS A NATIONAL REPOSITORY OF AUTOLOGOUS CRANIAL BONE FLAPS RECOVERED FROM LIVING PATIENTS DURING MEDICAL AND TRAUMATIC SURICAL PROCEDURES FOR REIMPLANTATION AT A LATER TIME. CTS PROVIDES HOSPITAL IN-SERVICE EDUCATION, HOSPITAL STAFF TRAINING, DOCUMENTATION, CRYOGENIC STORAGE, AND AUTOLOGOUS INTER-FACILITY TISSUE ESCORT SERVICES IN VALIDATED CONTAINERS FOLLOWING PROCEDURES MANDATED BY THE FDA. CTS IS REGISTERED WITH, AND SUBJECT TO THE REGULATORY AUTHORITY OF THE US FOOD AND DRUG ADMINISTRATION FOR THE DISTRIBUTION AND STORAGE OF HUMAN ALLOGRAFT AND AUTOLOGOUS TISSUE. CTS IS LICENSED AS A TISSUE BANK BY THE STATE OF CALIFORNIA DEPARTMENT OF HEALTH, IS A MEMBER OF THE EYE BANK ASSOCIATION OF AMERICA AND IS AN ACCREDITED INSTITUTIONAL MEMBER OF THE AMERICAN ASSOCITATION OF TISSUE BANKS. 1333030 1 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 1 0 0 0 0 0 0 0 0 0 0 0 0 X 4 2 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 CA X X DARYL LIRMAN 7608046890 5845 OWENS AVENUE CARLSBAD CA 92008 SUSAN DEBRHUL BOARD MEMBER 1.00 X 0 0 0 CHRISTIE HORN ESQ BOARD MEMBER 1.00 X 0 0 0 MARC PABLO CEBT CTBS MICP SR VP, BOARD MEMBER 65.00 X X 303150 0 14938 DARYL LIRMAN CTBS CEO/BOARD MEMBER 65.00 X X 302760 0 15085 605910 0 30023 2 0 1 0 0 20 20 EYE AND TISSUE BANK 541900 1936771 1936771 1936771 264043 264043 2200834 1936771 0 264043 635933 540543 95390 192469 157182 35287 12888 10955 1933 33476 28455 5021 4626 4626 9506 8080 1426 42398 37828 4570 27599 26959 640 2415 2415 179521 175931 3590 73596 69916 3680 TISSUE PROCESSING FEES 129150 129150 REPAIRS AND MAINTENANCE 38177 36268 1909 COURIERS 37236 36491 745 DUES-PROFESSIONAL ORGS 24007 22738 1269 55628 50119 5509 1498625 1333030 165595 0 735786 262394 6267900 7281920 314515 503330 171230 6231829 3427936 2888992 2803893 20000 30000 10227193 11052767 4612 607835 735812 612447 735812 X 9614746 10316955 9614746 10316955 10227193 11052767 702209 0 X X 0 1 X 1 0 X 5 26 23 20 74 1965807 2065388 1824601 1878957 1936771 9671524 1965807 2065393 1824627 1878980 1936791 9671598 0 0 0 9671598 31391 632379 243011 264043 1170824 31391 632379 243011 264043 1170824 871 5 876 1998069 2697777 1824627 2121991 2200834 10843298 0.89190 0.96090 0.10800 0.03640 X 1158674 1158674 3451592 1984555 1467037 234657 194145 40512 1386906 1249236 137670 2803893 PAYROLL LIABILITIES 735319 CREDIT CARD LIABILITY 493 735812 X 2200834 0 2200834 0 2200834 1498625 0 1498625 0 1498625 PART X, LINE 2: GAAP PROVIDES ACCOUNTING AND DISCLOSURE GUIDANCE ABOUT POSITIONS TAKEN BY AN ORGANIZATION IN ITS TAX RETURNS THAT MIGHT BE UNCERTAIN. MANAGEMENT BELIEVES THAT ALL TAX POSITIONS TAKEN BY THE ORGANIZATION IN ITS FEDERAL AND STATE EXEMPT ORGANIZATION TAX RETURNS ARE MORE LIKELY THAN NOT TO BE SUSTAINED UPON EXAMINATION. THE ORGANIZATION'S RETURNS ARE SUBJECT TO EXAMINATION BY FEDERAL AND STATE TAXING AUTHORITIES, GENERALLY FOR THREE AND FOUR YEARS, RESPECTIVELY, AFTER THEY ARE FILED. X X X X 0 0 0 0 0 0 0 0 0 MARC PABLO CEBT CTBS MICP SR VP, BOARD MEMBER 303150 0 0 0 0 0 0 0 14938 0 318088 0 0 0 DARYL LIRMAN CTBS CEO/BOARD MEMBER 302760 0 0 0 0 0 0 0 15085 0 317845 0 0 0 PART I, LINE 3 COMPENSATION IS DECIDED BY THE GOVERNING BODY AFTER TAKING INTO CONSIDERATION: 1) THE FUNCTIONAL DUTIES AND RESPONSIBILITIES, TIME AND TYPE OF RESPONSIBILITIES REQUIRED BY THE POSITION, NUMBER OF YEARS SERVED, CONSIDERATION FOR BEING THE FOUNDER OF THE CORPORATION, AND TAKING INTO ACCOUNT BEING THE TOP EXECUTIVE ACCOUNTABLE FOR THE GLOBAL OPERATIONAL ACTIVITIES OF THE FIRM. 2) CONSIDERATION OF SALARIES AND COMPENSATION PACKAGES OF CHIEF EXECUTIVE OFFICERS OF SIMILAR KIND OF ORGANIZATIONS WITH ADJUSTMENTS FOR FUNCTIONAL RESPONSIBILITIES, QUALIFICATION, AND REGIONAL LOCATION, 3) DISCUSSION WITH THE GOVERNING BOARD AND COMPENSATION COMMITTEE TO DETERMINE THE APPROPRIATENESS, ADEQUACY, AND AFFORDABILITY OF THE SALARY AND OTHER COMPENSATION SUCH AS COVERAGE BY THE FIRM'S GROUP MEDICAL PLAN. COMPENSATION IS ALSO REVIEWED TO TAKE INTO CONSIDERATION THE COST-OF-LIVING AND OF HOUSING IN THE AREA, AND 4) CONSIDERATION OF SURVEYED COMPENSATION OF OTHER COMPARABLE TISSUE FIRM EXECUTIVES AND STUDY OF COMPILED DATA REFLECTING CURRENT COMPENSATION IN THE TISSUE BANKING AND HEALTHCARE INDUSTRY. FORM 990, PART VI, SECTION B, LINE 11B THE TAX RETURN IS REVIEWED BY THE AUDIT COMMITTEE BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C CALIFORNIA TRANSPLANT SERVICES, INC. HAS A WRITTEN CONFLICT OF INTEREST POLICY AND IT IS AVAILABLE TO THE PUBLIC BY EITHER DIRECT REQUEST, OR ON OUR WEBSITE: HTTPS://WWW.SAFETYGRAFT.COM/CONFLICT%20OF%20INTEREST%20010109.PDF . THE POLICY IS MONITORED, REVIEWED AND ENFORCED ANNUALLY OR AS NECESSARY. ALL EMPLOYEES ARE REQUIRED UNDER THE POLICY TO REVIEW AND SIGN AN ACKNOWLEDGMENT OF THE CALIFORNIA TRANSPLANT SERVICES, INC. CONFLICT OF INTEREST POLICY. A SIGNATURE ON AN ANNUAL BASIS ACKNOWLEDGES THE FOLLOWING: 1) HAS RECEIVED A COPY OF THE CONFLICT OF INTEREST POLICY 2) HAS READ AND UNDERSTANDS THE POLICY; AND 3) HAS AGREED TO COMPLY WITH THE POLICY; AND 4) UNDERSTANDS THAT THE CALIFORNIA TRANSPLANT SERVICES, INC. IS A CHARITABLE 501(C)(3) ORGANIZATION, AND THAT IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. ENFORCEMENT OF THE POLICY IS AS FOLLOWS: IF THE BOARD OR COMMITTEE HAS REASONABLE CAUSE TO BELIEVE THAT A MEMBER HAS FAILED TO DISCLOSE ACTUAL OR POSSIBLE CONFLICTS OF INTEREST, IT SHALL INFORM THE MEMBER OF THE BASIS FOR SUCH A BELIEF AND AFFORD THE MEMBER AN OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE. IF, AFTER INVESTIGATION OF THE FACTS AND HEARING THE RESPONSE OF THE MEMBER AND MAKING FURTHER INVESTIGATION AS MAY BE WARRANTED BY THE CIRCUMSTANCES, THE BOARD OR TASK FORCE COMMITTEE DETERMINES THAT THE MEMBER HAS IN FACT FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT SHALL TAKE APPROPRIATE CORRECTIVE OR DISCIPLINARY ACTION. FORM 990, PART VI, SECTION B, LINE 15A IS DECIDED BY THE GOVERNING BODY AFTER TAKING INTO CONSIDERATION: 1) THE FUNCTIONAL DUTIES AND RESPONSIBILITIES, TIME AND TYPE OF RESPONSIBILITIES REQUIRED BY THE POSITION, NUMBER OF YEARS SERVED, CONSIDERATION FOR BEING THE FOUNDER OF THE CORPORATION, AND TAKING INTO ACCOUNT BEING THE TOP EXECUTIVE ACCOUNTABLE FOR THE GLOBAL OPERATIONAL ACTIVITIES OF THE FIRM. 2) CONSIDERATION OF SALARIES AND COMPENSATION PACKAGES OF CHIEF EXECUTIVE OFFICERS OF SIMILAR KIND OF ORGANIZATIONS WITH ADJUSTMENTS FOR FUNCTIONAL RESPONSIBILITIES, QUALIFICATION, AND REGIONAL LOCATION, 3) DISCUSSION WITH THE GOVERNING BOARD AND COMPENSATION COMMITTEE TO DETERMINE THE APPROPRIATENESS, ADEQUACY, AND AFFORDABILITY OF THE SALARY AND OTHER COMPENSATION SUCH AS COVERAGE BY THE FIRM'S GROUP MEDICAL PLAN. COMPENSATION IS ALSO REVIEWED TO TAKE INTO CONSIDERATION THE COST-OF-LIVING AND OF HOUSING IN THE AREA, AND 4) CONSIDERATION OF SURVEYED COMPENSATION OF OTHER COMPARABLE TISSUE FIRM EXECUTIVES AND STUDY OF COMPILED DATA REFLECTING CURRENT COMPENSATION IN THE TISSUE BANKING AND HEALTHCARE INDUSTRY. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO ANYONE REQUESTING THE DOCUMENTS UPON WRITTEN REQUEST TO CALIFORNIA TRANSPLANT SERVICES, INC. STATE AND LOCAL LICENSES, FDA REGISTRATION, THE CONFLICT OF INTEREST AND WHISTLE BLOWER POLICIES ARE AVAILABLE FOR REVIEW ON THE CTS WEBSITE: CATRANSPLANT.ORG. CTS' FORM 990, FORM CA 199, SCHEDULES AND FINANCIAL STATEMENTS ARE POSTED ON THE WEBSITE GUIDESTAR.COM, AND ARE AVAILABLE FOR PUBLIC DOWNLOAD FROM THE WEBSITE. FORM 990, PART XII, LINE 2C: THE ORGANIZATION HAS NOT CHANGED OVERSIGHT OR SELECTION PROCESS DURING THE TAX YEAR. FORM 990, PART IV, LINE 12A AND SCHEDULE D PART XII THE ORGANIZATION'S 2023 FINANCIAL STATEMENT AUDIT IS IN-PROCESS AS OF THE DATE OF THIS FILING.